Glaucoma Prediction via Archetypal Visual Field Decomposition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to accurately predict clinical parameters related to glaucoma from central visual field patterns, which is crucial for early detection and intervention in glaucoma progression.

Innovation Solution

A system utilizing a processor and machine learning model that decomposes visual field data into archetypal patterns, generating decomposition coefficients to determine clinical parameters, including glaucoma severity, through archetypal analysis and pattern decomposition, enabling informed clinical decisions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current methods are used to predict clinical parameters from central visual field patterns, then the prediction accuracy is insufficient, but the complexity of the system remains high

Engineering Contradiction:
Improveprediction accuracyVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the visual field data into distinct archetypal patterns (e.g., nasal step, temporal step, arcuate patterns) through archetypal analysis. This segmentation allows the complex visual field data to be broken down into manageable, interpretable components that can be systematically analyzed and correlated with clinical parameters, thereby improving prediction accuracy while maintaining manageable system complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces archetypal patterns as intermediary representations between the raw visual field data and the clinical parameters. These archetypal patterns serve as a mediator that translates complex visual field measurements into meaningful clinical insights, enabling accurate prediction without requiring overly complex direct modeling approaches

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If archetypal analysis is applied to decompose visual field data, then the ability to categorize patterns improves, but the computational requirements increase

Engineering Contradiction:
Improvepattern categorization capabilityVSAvoidcomputational resources
Core Design Contradiction:
Adaptability or versatilityVSUse of energy by moving object

Solution Approach 1:

The patent performs archetypal analysis and pattern decomposition as preliminary actions during the data processing stage. By pre-computing the archetypal patterns and their decomposition coefficients, the system prepares the data in advance for subsequent clinical parameter prediction, thereby improving pattern categorization capability while managing computational resources through efficient preprocessing

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20240049960A1Predicting clinical parameters relating to glaucoma from central visual field patterns
Publication Date: 2024.02.15 MASSACHUSETTS EYE & EAR INFARY
  • US20240049960A1 patent drawing
  • US20240049960A1 patent drawing
  • US20240049960A1 patent drawing

AI summary

Systems and methods are provided for predicting clinical parameters relating to glaucoma from central visual field patterns. A system includes a processor, an output device, and a computer readable medium that stores executable instructions. The instructions provide a pattern decomposition component that receives a set of visual field data for a patient representing, for each of a plurality of locations in the central region of an eye of the patient, a deviation in sensitivity to a visual stimulus from an age-adjusted normal value and decomposes the set of visual field data into a linear combination of a set of patterns defined via archetypal analysis over a corpus of visual field data to provide a set of decomposition coefficients. A machine learning model determines a clinical parameter for the patient from at least the set of decomposition coefficients, and a user interface provides the determined clinical parameter to a user.